The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease

Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease

(2019) Zubin J. Modi et al.   JAMA Cardiology

Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease

(2019) Agnieszka Kuchta et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis

(2019) Keiko Kawachi et al.   HEART AND VESSELS

High-Density Lipoprotein Function and Dysfunction in Health and Disease

(2019) Scott T. Chiesa et al.   CARDIOVASCULAR DRUGS AND THERAPY

Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome

(2019) Alice Ossoli et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Relationship Between HDL Functional Characteristics and Cardiovascular Health and Potential Impact of Dietary Patterns: A Narrative Review

(2019) Allison S. Bardagjy et al.   Nutrients

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

(2019) Andrew A. House et al.   KIDNEY INTERNATIONAL

APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice

(2019) Jung-Hwa Ryu et al.   PLoS One

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients

(2019) Sébastien Tanaka et al.   Annals of Intensive Care

Chronic Kidney Disease and Coronary Artery Disease

(2019) Mark J. Sarnak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study

(2018) Matthew B. Lanktree et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

High-density lipoprotein (HDL) cholesterol – more complicated than we think?

(2018) Katarzyna Nessler et al.   ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE

Disorders of Lipid Metabolism in Chronic Kidney Disease

(2018) Mustafa C.  Bulbul et al.   BLOOD PURIFICATION

Metabolic characterization of menopause: cross-sectional and longitudinal evidence

(2018) Qin Wang et al.   BMC Medicine

Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real

(2018) C. Noel Bairey Merz et al.   CURRENT OPINION IN CARDIOLOGY

Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within

(2018) Sarina Kajani et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients

(2018) Kathrin Untersteller et al.   JOURNAL OF LIPID RESEARCH

HDL in CKD—The Devil Is in the Detail

(2018) Florian Kronenberg   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency

(2018) Agnieska Ćwiklińska et al.   KIDNEY & BLOOD PRESSURE RESEARCH

OUP accepted manuscript

(2018)   NEPHROLOGY DIALYSIS TRANSPLANTATION

Inflammation, not Cholesterol, Is a Cause of Chronic Disease

(2018) Alexandros Tsoupras et al.   Nutrients

Alteration of HDL Protein Composition with Hemodialysis Initiation

(2018) Ke Wang et al.   Clinical Journal of the American Society of Nephrology

New perspectives on CKD-induced dyslipidemia

(2017) Marcelino Bermúdez-López et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease

(2017) Agnieszka Kuchta et al.   Journal of Cardiology

Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate

(2017) Laurence Perségol et al.   JOURNAL OF LIPID RESEARCH

Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease

(2017) Xiao-min Bu et al.   Lipids in Health and Disease

The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk

(2017) Marek Femlak et al.   Lipids in Health and Disease

SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis

(2017) MacRae F. Linton et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Prevalence, incidence and associated mortality of cardiovascular disease in patients with chronic kidney disease in low- and middle-income countries: a protocol for a systematic review and meta-analysis

(2017) Mazou N Temgoua et al.   BMJ Open

Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features

(2017) Irina Florina Tudorache et al.   Computational and Structural Biotechnology Journal

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112Novelty and Significance

(2016) Svetlana A. Didichenko et al.   CIRCULATION RESEARCH

The Changing Face of HDL and the Best Way to Measure It

(2016) Sotirios K. Karathanasis et al.   CLINICAL CHEMISTRY

High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease

(2016) Hirokazu Honda et al.   Journal of Atherosclerosis and Thrombosis

Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression

(2016) Samar R. El Khoudary et al.   Journal of Clinical Lipidology

HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications

(2016) Yufeng Li et al.   Lipids in Health and Disease

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins

(2016) Nans Florens et al.   Toxins

Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality

(2016) Taulant Muka et al.   JAMA Cardiology

Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population

(2016) Michael Thompson et al.   Journal of Clinical Medicine

Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies

(2016) Sabrina Schlesinger et al.   PLoS One

HDL particle subpopulations: Focus on biological function

(2015) Fabiana H. Rached et al.   BIOFACTORS

A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects

(2015) Baohai Shao et al.   JOURNAL OF PROTEOME RESEARCH

Dialysis Modalities and HDL Composition and Function

(2015) M. Holzer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Dysfunctional high-density lipoproteins in children with chronic kidney disease

(2015) Ryohei Kaseda et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

HDL abnormalities in nephrotic syndrome and chronic kidney disease

(2015) Nosratola D. Vaziri   Nature Reviews Nephrology

Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies

(2015) P. Willeit et al.   Journal of the American Heart Association

High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease

(2014) A. Kratzer et al.   CARDIOVASCULAR RESEARCH

High-density lipoprotein as a modulator of platelet and coagulation responses

(2014) M. van der Stoep et al.   CARDIOVASCULAR RESEARCH

High-Density Lipoprotein

(2014) Thomas F. Lüscher et al.   CIRCULATION RESEARCH

Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis

(2014) C. Kopecky et al.   Clinical Journal of the American Society of Nephrology

Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease

(2014) L. Calabresi et al.   JOURNAL OF INTERNAL MEDICINE

HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction

(2014) S. Zewinger et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype

(2014) R. Shroff et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties

(2014) C. Kopecky et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients

(2014) G. Silbernagel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

An abundant dysfunctional apolipoprotein A1 in human atheroma

(2014) Ying Huang et al.   NATURE MEDICINE

Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients

(2014) H. Moradi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology

(2014) Ruth Birner-Gruenberger et al.   PROGRESS IN LIPID RESEARCH

Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease

(2013) Meliana Riwanto et al.   CIRCULATION

Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants

(2013) Kaoru Ito et al.   CIRCULATION RESEARCH

High-density lipoproteins: A consensus statement from the National Lipid Association

(2013) Peter P. Toth et al.   Journal of Clinical Lipidology

Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus - apost hocanalysis of the 4D Study

(2013) B. Kollerits et al.   JOURNAL OF INTERNAL MEDICINE

Unraveling the complexities of the HDL lipidome

(2013) Anatol Kontush et al.   JOURNAL OF LIPID RESEARCH

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond

(2013) Amy S. Shah et al.   JOURNAL OF LIPID RESEARCH

Role of HDL Dysfunction in End-Stage Renal Disease: A Double-Edged Sword

(2013) Hamid Moradi et al.   JOURNAL OF RENAL NUTRITION

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

(2013) Ron T Gansevoort et al.   LANCET

High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals

(2012) Michał Ząbczyk et al.   BLOOD COAGULATION & FIBRINOLYSIS

High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A

(2012) Markus Tölle et al.   CARDIOVASCULAR RESEARCH

Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis

(2012) Suguru Yamamoto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Inflammation alters HDL composition and function: Implications for HDL-raising therapies

(2012) Gunther Marsche et al.   PHARMACOLOGY & THERAPEUTICS

Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?

(2012) Aneta Otocka-Kmiecik et al.   PROGRESS IN LIPID RESEARCH

Elevated Non-high-density Lipoprotein Cholesterol (Non-HDL-C) Predicts Atherosclerotic Cardiovascular Events in Hemodialysis Patients

(2011) T. Shoji et al.   Clinical Journal of the American Society of Nephrology

Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway

(2011) Qiuhua Zhang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans

(2011) Shusaku Maeda et al.   Journal of Atherosclerosis and Thrombosis

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Racial and Ethnic Differences in Kidney Function Decline among Persons without Chronic Kidney Disease

(2011) C. A. Peralta et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy

(2011) J. B. Kopp et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Uremia Alters HDL Composition and Function

(2011) M. Holzer et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Prevention of cardiovascular disease in adult recipients of kidney transplants

(2011) Alan G Jardine et al.   LANCET

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans

(2011) Barry I. Freedman et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Future Therapeutic Directions in Reverse Cholesterol Transport

(2010) Amit V. Khera et al.   Current Atherosclerosis Reports

Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export

(2010) Baohai Shao et al.   JOURNAL OF LIPID RESEARCH

Lipotoxicity and Impaired High Density Lipoprotein-Mediated Reverse Cholesterol Transport in Chronic Kidney Disease

(2010) Nosratola D. Vaziri   JOURNAL OF RENAL NUTRITION

Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation

(2009) C. A. Derby et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity

(2009) Amal Zerrad-Saadi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters

(2009) W. Sean Davidson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal women

(2009) Shlomo Keidar et al.   Journal of Clinical Lipidology

Women and Ischemic Heart Disease

(2009) Leslee J. Shaw et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Causes of Dysregulation of Lipid Metabolism in Chronic Renal Failure

(2009) Nosratola D. Vaziri   SEMINARS IN DIALYSIS

Antiinflammatory Actions of HDL

(2008) Kerry-Anne Rye et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis

(2008) Alan R. Tall et al.   Cell Metabolism

Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?

(2008) P. Stenvinkel et al.   Clinical Journal of the American Society of Nephrology